Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer

Abstract

Of late, nimbolide, a limonoid from the neem tree (Azadirachta indica) has gained increasing research attention owing to its potent antiproliferative and apoptosis-inducing effects. The present study was designed to investigate the effect of nimbolide on autophagy and the time point at which the phosphorylation status of GSK-3β and PI3K dictate the choice between autophagy and apoptosis in SCC131 and SCC4 oral cancer cells. Additionally, we analysed changes in the expression of proteins involved in autophagy and apoptosis after therapeutic intervention with nimbolide in a hamster model of oral oncogenesis. Furthermore, we also demonstrate changes in the expression of key genes involved in apoptosis and autophagy during the stepwise evolution of hamster and human OSCCs. Nimbolide-induced stereotypical changes in oral cancer cells characteristic of both apoptosis and autophagy. Time-course experiments revealed that nimbolide induces autophagy as an early event and then switches over to apoptosis. Nimbolide negatively regulates PI3K/Akt signalling with consequent increase in p-GSK-3βTyr216, the active form of GSK-3β that inhibits autophagy. Downregulation of HOTAIR, a competing endogenous RNA that sponges miR-126 may be a major contributor to the inactivation of PI3K/Akt/GSK3 signalling by nimbolide. Analysis of key markers of apoptosis and autophagy as well as p-AktSer473 during sequential progression of hamster and human OSCC revealed a gradual evolution to a pro-autophagic and antiapoptotic phenotype that could confer a survival advantage to tumors. In summary, the results of the present study provide insights into the molecular mechanisms by which nimbolide augments apoptosis by overcoming the shielding effects of cytoprotective autophagy through modulation of the phosphorylation status of Akt and GSK-3β as well as the ncRNAs miR-126 and HOTAIR. Development of phytochemicals such as nimbolide that target the complex interaction between proteins and ncRNAs that regulate the autophagy/apoptosis flux is of paramount importance in cancer prevention and therapeutics.

Autophagy inhibition potentiates the anti-EMT effects of alteronol through TGF-β/Smad3 signaling in melanoma cells

“…Cell viability and colony formation assay were performed as described previously 21,22 . Briefly, cells were seeded in 96-well plates (5000 cells/well) and then were subjected to various indicated treatments.…”

“…Cell apoptosis was measured using an Annexin V-FITC/ PE Apoptosis kit (BD Biosciences, San Jose, USA) according to the manufacturer's instructions 22 . Briefly, cells were plated into a six-well plate (5 × 10 4 cells/well) for 24 h and then subjected to various indicated treatments.…”

TAF1L promotes development of oral squamous cell carcinoma via decreasing autophagy-dependent apoptosis

“…phytochemical agents induced cell apoptosis was through reducing autophagy in tumors [43][44][45][46]. As a potential protumor gene, TAF1L may have an important role as a regulator in response to the stresses for the apoptosis of cancer, which functions are similar to TAF1 gene (its homologous family member) [20].…”

Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas

“…Predominantly, it was demonstrated that 44 was negatively modulating the PI3K/Akt pathway by the increase of phosphorylated glycogen synthase kinase‐3β (p‐GSK‐3β, involved in the regulation of autophagy and apoptosis based on its phosphorylation status). The increased levels of p‐GSK‐3β silenced the preliminary autophagy activating the apoptosis …”